Employment status and desire for work in severe mental illness: results from an observational, cross-sectional study.
Desire to work
Employment status
Predictors
Supported employment
Work ability
Journal
Social psychiatry and psychiatric epidemiology
ISSN: 1433-9285
Titre abrégé: Soc Psychiatry Psychiatr Epidemiol
Pays: Germany
ID NLM: 8804358
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
19
08
2020
accepted:
07
04
2021
pubmed:
17
4
2021
medline:
14
9
2021
entrez:
16
4
2021
Statut:
ppublish
Résumé
People with a severe mental illness (SMI) are at particular risk of occupational exclusion. Among the approaches to occupational rehabilitation, supported employment (SE) has been proven to be the most effective. A requirement to enter SE-programs is that individuals must want to seek competitive employment. The aim of this work is to investigate the relationship between serious mental illness and the desire to work including potential predictors. This is a cross-sectional observational study of patients with SMI aged 18-65 years (n = 397). Patients were interviewed by trained staff using standardised instruments. The relationship between potential predictors and a strong preference for employment were analysed using a hierarchic binary logistic regression model. Only about one-quarter (27.9%) of SMI patients is in competitive employment. Another quarter is unemployed (25.9%). Results show that the desire for competitive employment is strong among more than half of the SMI patients. Among the unemployed, two-thirds express a strong desire for work. These individuals are an ideal target group for SE interventions. Comorbid chronic physical illness, diagnosis, and the subjectively judged ability to work are associated with the desire for work. Our data confirm a substantial exclusion of individuals with SMI from the workforce. In general, care needs for workplace interventions are not being met and leave much room for improvement. In addition to employment status, the desire for work should be routinely assessed. The study was registered in the German Clinical Trials Register (DRKS) ( https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00015801 ) and under the WHO-Platform "International Clinical Trials Registry Platform" (ICTRP) ( https://apps.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00015801 ) under the registration number DRKS00015801 before the start of recruitment (Registration date: 21.02.2019).
Identifiants
pubmed: 33860804
doi: 10.1007/s00127-021-02088-8
pii: 10.1007/s00127-021-02088-8
pmc: PMC8429146
doi:
Banques de données
DRKS
['DRKS00015801']
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1657-1667Subventions
Organisme : Innovationsfond des Gemeinsamen Bundesausschusses (G-BA)
ID : 01VSF17017
Informations de copyright
© 2021. The Author(s).
Références
BMC Psychiatry. 2020 Jun 8;20(1):288
pubmed: 32513133
Psychiatr Prax. 2003 Sep;30(6):312-7
pubmed: 12970816
Psychiatr Rehabil J. 2008 Spring;31(4):291-5
pubmed: 18407877
Int J Environ Res Public Health. 2019 Sep 12;16(18):
pubmed: 31547466
Br J Psychiatry. 2016 Jul;209(1):14-22
pubmed: 27103678
Soc Psychiatry Psychiatr Epidemiol. 2012 Sep;47(9):1381-9
pubmed: 22083390
Psychiatr Prax. 2020 Jul;47(5):235-241
pubmed: 32198734
J Ment Health. 2015 Aug;24(4):196-201
pubmed: 26207510
Am J Psychiatry. 2014 Nov 1;171(11):1183-90
pubmed: 25124692
Nervenarzt. 2016 Nov;87(11):1144-1151
pubmed: 27649985
Cult Med Psychiatry. 2016 Sep;40(3):507-32
pubmed: 26581838
Scand J Occup Ther. 2013 Nov;20(6):420-8
pubmed: 23387398
Int J Methods Psychiatr Res. 2010 Mar;19(1):50-62
pubmed: 20191659
Soc Psychiatry Psychiatr Epidemiol. 2006 Jun;41(6):457-63
pubmed: 16565917
Schizophr Bull. 2013 Jul;39(4):908-16
pubmed: 22328642
J Nerv Ment Dis. 2010 Aug;198(8):556-63
pubmed: 20699720
J Nerv Ment Dis. 2013 Mar;201(3):173-8
pubmed: 23417014
Psychiatr Prax. 2001 Oct;28 Suppl 2:S84-90
pubmed: 11605129
Cochrane Database Syst Rev. 2017 Sep 12;9:CD011867
pubmed: 28898402
Psychother Psychosom Med Psychol. 2015 Sep;65(9-10):383-6
pubmed: 26422311
Schizophr Bull. 2001;27(2):281-96
pubmed: 11354595
Psychiatr Rehabil J. 2008 Winter;31(3):243-6
pubmed: 18194953
Soc Psychiatry Psychiatr Epidemiol. 2004 May;39(5):337-49
pubmed: 15133589
Aust N Z J Psychiatry. 2010 Jun;44(6):495-504
pubmed: 20482409
Psychiatr Prax. 2017 Mar;44(2):65-74
pubmed: 26979623
Epidemiol Psychiatr Sci. 2020 Nov 13;29:e183
pubmed: 33185176
Adm Policy Ment Health. 2001 Mar;28(4):279-97
pubmed: 11577655
Psychiatr Serv. 2020 Mar 1;71(3):250-255
pubmed: 31722646
Front Psychiatry. 2020 Aug 27;11:856
pubmed: 33192630
J Nerv Ment Dis. 2012 Mar;200(3):214-22
pubmed: 22373758
Schizophr Res. 2016 Oct;176(2-3):462-466
pubmed: 27567733
Eur Neuropsychopharmacol. 2014 Nov;24(11):1767-72
pubmed: 25219937
Psychiatr Prax. 2015 Nov;42(8):415-23
pubmed: 26540523
Br J Psychiatry. 1995 May;166(5):654-9
pubmed: 7620753
PLoS One. 2018 Oct 2;13(10):e0204809
pubmed: 30278081
Psychiatr Prax. 2018 May;45(4):197-205
pubmed: 28499318
Front Psychiatry. 2019 Jul 19;10:518
pubmed: 31379630
J Occup Rehabil. 2015 Jun;25(2):423-31
pubmed: 25354750
Psychiatr Prax. 2020 Jul;47(5):273-280
pubmed: 32198736
Br J Psychiatry. 1998 Jan;172:11-8
pubmed: 9534825